NYSE:NUS

Nu Skin Enterprises Stock Forecast, Price & News

$53.81
+0.54 (+1.01 %)
(As of 07/28/2021 12:00 AM ET)
Add
Compare
Today's Range
$53.09
$54.28
50-Day Range
$52.27
$62.44
52-Week Range
$43.41
$63.85
Volume272,688 shs
Average Volume528,398 shs
Market Capitalization$2.69 billion
P/E Ratio12.81
Dividend Yield2.85%
Beta1.18
30 days | 90 days | 365 days | Advanced Chart
Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.


Nu Skin Enterprises logo

About Nu Skin Enterprises

Nu Skin Enterprises, Inc. develops and distributes personal care products and nutritional supplements. The firm engages in the provision of beauty and wellness products and solutions. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.31 out of 5 stars

Consumer Staples Sector

38th out of 328 stocks

Drugs, Proprietaries, & Sundries Industry

2nd out of 16 stocks

Analyst Opinion: 2.1Community Rank: 3.4Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

Is Nu Skin Enterprises a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Nu Skin Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View analyst ratings for Nu Skin Enterprises
or view top-rated stocks.

What stocks does MarketBeat like better than Nu Skin Enterprises?

Wall Street analysts have given Nu Skin Enterprises a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nu Skin Enterprises wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 2,670,000 shares, a decrease of 13.9% from the June 30th total of 3,100,000 shares. Based on an average trading volume of 520,300 shares, the short-interest ratio is currently 5.1 days. Approximately 5.4% of the company's stock are sold short.
View Nu Skin Enterprises' Short Interest
.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Nu Skin Enterprises
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) issued its earnings results on Wednesday, May, 5th. The company reported $0.91 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.72 by $0.19. The company had revenue of $677.03 million for the quarter, compared to analysts' expectations of $633.26 million. Nu Skin Enterprises had a trailing twelve-month return on equity of 25.88% and a net margin of 7.99%.
View Nu Skin Enterprises' earnings history
.

How has Nu Skin Enterprises' stock been impacted by Coronavirus?

Nu Skin Enterprises' stock was trading at $21.06 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NUS stock has increased by 155.5% and is now trading at $53.81.
View which stocks have been most impacted by COVID-19
.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises declared a quarterly dividend on Thursday, May 6th. Investors of record on Friday, May 28th will be given a dividend of $0.38 per share on Wednesday, June 9th. This represents a $1.52 annualized dividend and a yield of 2.82%. The ex-dividend date of this dividend is Thursday, May 27th.
View Nu Skin Enterprises' dividend history
.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises pays an annual dividend of $1.52 per share and currently has a dividend yield of 2.85%. Nu Skin Enterprises does not yet have a strong track record of dividend growth. The dividend payout ratio of Nu Skin Enterprises is 41.87%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 34.00% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.
View Nu Skin Enterprises' dividend history.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its FY 2021 earnings guidance on Wednesday, May, 26th. The company provided EPS guidance of 4.050-4.300 for the period, compared to the Thomson Reuters consensus estimate of $3.990. The company issued revenue guidance of $2.80 billion-$2.87 billion, compared to the consensus revenue estimate of $2.78 billion.

What price target have analysts set for NUS?

5 equities research analysts have issued 1-year price objectives for Nu Skin Enterprises' shares. Their forecasts range from $55.00 to $66.00. On average, they expect Nu Skin Enterprises' share price to reach $60.20 in the next year. This suggests a possible upside of 11.9% from the stock's current price.
View analysts' price targets for Nu Skin Enterprises
or view top-rated stocks among Wall Street analysts.

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the following people:
  • Ritch N. Wood, Chief Executive Officer
  • Ryan S. Napierski, President, CEO-Elect & Director
  • Mark H. Lawrence, Chief Financial Officer & Executive Vice President
  • Joseph Y. Chang, Chief Scientific Officer & EVP-Product Development
  • Helen E. Knaggs, Vice President-Global Research & Development

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises CEO Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among Nu Skin Enterprises' employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Nu Skin Enterprises' key competitors?

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a number of retail and institutional investors. Top institutional investors include Oregon Public Employees Retirement Fund (0.03%), New Mexico Educational Retirement Board (0.02%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Foulis Greg, James D Thomas, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends for Nu Skin Enterprises
.

Which major investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, James D Thomas, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, and Ryan S Napierski.
View insider buying and selling activity for Nu Skin Enterprises
or view top insider-selling stocks.

Which major investors are buying Nu Skin Enterprises stock?

NUS stock was acquired by a variety of institutional investors in the last quarter, including New Mexico Educational Retirement Board, and Oregon Public Employees Retirement Fund. Company insiders that have bought Nu Skin Enterprises stock in the last two years include Ritch N Wood, and Steven Lund.
View insider buying and selling activity for Nu Skin Enterprises
or or view top insider-buying stocks.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $53.81.

How much money does Nu Skin Enterprises make?

Nu Skin Enterprises has a market capitalization of $2.69 billion and generates $2.58 billion in revenue each year. The company earns $191.35 million in net income (profit) each year or $3.63 on an earnings per share basis.

How many employees does Nu Skin Enterprises have?

Nu Skin Enterprises employs 5,000 workers across the globe.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is www.nuskinenterprises.com.

Where are Nu Skin Enterprises' headquarters?

Nu Skin Enterprises is headquartered at 75 WEST CENTER ST, PROVO UT, 84601.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at (801) 345-1000 or via email at [email protected]


This page was last updated on 7/29/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.